The Fund Overview provides LPs with general information about the fund allowing them easy access to the fund’s terms and “standing data” without requiring them to consult the fund formation documents. Many GPs utilise structures which include parallel funds to meet the needs of individual LPs; however, the Fund Overview would normally be expected to cover the total fund position aggregating all parallel funds, unless there are different contractual terms which may require additional disclosure.
The Fund Overview is designed to be a one-page summary of the fund structure. Where effective disclosure is incompatible with one-page disclosure, it may be appropriate to include only a cross-reference to the fund formation documents or other sources.
The Executive Summary gives the GP an opportunity to provide LPs with information concerning key developments and current activity in the fund over the reporting period without the need for the LP to review the whole report to discover significant items. The relevant reporting period will either be the current quarter, the year-to-date period or both depending on the circumstances of the fund.
This will enable LPs to assess at a high level the progress of the fund and its investments over the reporting period.
Commentary on:
Where relevant:
The Fund Performance Status should aim to provide LPs with sufficient information to assess the performance of the fund as a whole, as well as details of the remaining commitments and the expected investment time frame.
A summary of:
A set of Financial Statements is a fundamental part of any reporting package, demonstrating good financial control and giving an overview of the performance and financial position of the fund. Such statements should be reported at the appropriate level (i.e., partnership/entity or whole fund) within the overall fund structure.
It would be typical for a manager to provide only annually a set of comprehensive financial statements that meet local regulatory requirements. However, abridged financial information will be more appropriate. This abridged financial information should be based on Fair Value but need not be in GAAP format/layout.
Reports to investors should normally include a set of abridged financial statements for the period in question with relevant comparatives:
The statements should be presented so as to allow the reader to distinguish between portfolio/investment-related matters (e.g., gross investment return) and those related to the fund structure (e.g., fees, carried interest, expenses, etc.).
Ideally, the abridged financial statements should allow the investor to see aggregate performance both on a whole fund basis as well as at the level of the partnership/entity in which they are invested. This is to ensure that, when read in conjunction with the investor’s capital account (as illustrated here), the investor can track information from the whole fund level down to their individual share of the fund.
Besides, the following information would be valuable if disclosed:
Information on amounts earned by the GP from the fund and portfolio companies together with the fund operating expenses should be disclosed in order to verify compliance with the fund formation documents. In addition, management fees, transaction and other fees and carried interest arrangements are unique to each fund and such disclosure provides transparency to investors.
The information below should be reported for the current reporting period, year to date (or last twelve months) and, if available, since inception. In addition, where a material difference has been identified between the audited accounts and the relevant report, a reconciliation of the difference should be disclosed and explained.
Management fees paid or payable to the GP by the fund should be disclosed together with the basis of calculation;
In some funds, certain transaction fees and other service fees earned by the GP from the portfolio company (see below) are offset against the management fees either in full or in part. If this is applicable, then the disclosure of management fees should show the gross management fees paid or payable to the GP, the amount of the offset applied in respect of the transaction and other fees, and the net management fees. It should be clear from the disclosure what percentage offset applies.
The nature and source of all benefits and fees paid directly or indirectly by portfolio companies to the GP and/or any related entities/individuals (such as employees, operating partners, advisers or similar) should be disclosed. Typically, these items will include but not be limited to arrangement fees, underwriting fees, directors’ and monitoring fees and transaction fees (including those earned at the time of investment and sale, where relevant). The treatment of such fees will be specific to each individual fund, often determined in the fund formation documents and the reporting should show clearly the treatment adopted.
Disclosure of whether the hurdle rate has been exceeded;
Carried interest earned on the realised and unrealised portfolio should be disclosed with a breakdown of the following items:
Total amount of carried interest earned from realisations, indicating how much has been distributed;
If undistributed carried interest is held in escrow, then the amount in question should be disclosed;
Total amount of carried interest payable on unrealised investments assuming they are realised at the current fair value;
Value of any potential clawbacks of carried interest (this is unlikely where the fund is structured with whole fund carry).
Disclosure of the fund’s operating expenses providing a breakdown by category as is appropriate. This would typically include expenses such as audit, tax, Portfolio Investment legal, Fund legal and Annual Investor Meeting costs. Separate disclosure should be made, where relevant, for fund formation costs, fund borrowing costs (including interest expense and fees) and aborted deal costs. (The information may be disclosed in the fund financial statements.)
Where disclosures are being made of information in accordance with the fund formation documents, consideration should be given to annotating references to specific sections of the fund formation documents where relevant;
Transaction and other fees may also be analysed by Portfolio Investment;
Total Expense Ratio.
In recent years it has become common practice for GPs to use Bridge Finance facilities within fund structures. These are used by GPs for a range of efficiency reasons including consolidating the volume of Capital Calls made to and from LPs and avoiding the need to draw funds from LPs for temporary investments or to allow the GP to respond more rapidly to emerging investment opportunities. Lack of standardised information on financing facilities makes it difficult to compare underlying performance across funds and for LPs to establish their underlying exposures in each fund. To allow for such comparability, the following requirements and additional possible disclosures have been included in these Guidelines.
Disclosure should comprise details of any Bridge Finance, Fund Leverage, and other credit facilities (including borrowings that are within a fund level SPV), which may include:
On a quarterly basis, the GP should disclose, either as part of disclosure under Fund performance status (Example 3), as part of GP Fees, Carried Interest and Fund Operating Expenses (Example 7), or alternatively as part of a separate disclosure: